» Articles » PMID: 20300742

Norwegian Medical Students' Attitudes Towards the Pharmaceutical Industry

Overview
Specialty Pharmacology
Date 2010 Mar 20
PMID 20300742
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Whereas there is a considerable body of information on the interaction between physicians and the pharmaceutical industry, little is known about the pharmaceutical industry-medical student relationship. We have assessed the extent of contact between Norwegian medical students and the pharmaceutical industry as well as the attitudes of these students towards the pharmaceutical industry.

Methods: A self-assessment questionnaire was distributed to fifth- and sixth-year students attending the four medical schools in Norway and to Norwegian medical students attending selected universities abroad.

Results: A total of 65.8% of all eligible students returned a completed questionnaire. Of these, 73.9% had been exposed to various levels of contact with the pharmaceutical industry, but only 17.5% reported having a generally positive attitude towards the industry. The level of exposure did not correlate in students' attitudes; rather, it correlated positively to a feeling of competence in terms of being able to handle such interactions. A majority of students responded that while they would decline accepting monetary gifts, they would welcome receiving reimbursements for meeting expenses, meals and educational material. Students favoured a practice of full disclosure of potential industry-related conflicts of interest among the university teaching staff. There were considerable differences in the students' attitudes between universities, suggesting that medical students are prone to influence from university lecturers.

Conclusions: Norwegian medical students are opinionated, critical and curious with respect to pharmaceutical industry relations. This interest can be explored and probably also modified by educational initiatives.

Citing Articles

Medical students' exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France.

Molina M, Boeffard A, Esvan M, Bastian B BMJ Open. 2022; 12(7):e045671.

PMID: 35858728 PMC: 9305804. DOI: 10.1136/bmjopen-2020-045671.


Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.

Murayama A, Senoo Y, Harada K, Kotera Y, Saito H, Sawano T Int J Environ Res Public Health. 2022; 19(6).

PMID: 35329160 PMC: 8952770. DOI: 10.3390/ijerph19063478.


Conflict of interest policies at Belgian medical faculties: Cross-sectional study indicates little oversight.

Bechoux L, De Vleeschouwer O, Vanheuverzwijn C, Verhegghen F, Detiffe A, Colle F PLoS One. 2021; 16(2):e0245736.

PMID: 33566836 PMC: 7875358. DOI: 10.1371/journal.pone.0245736.


Quantity and quality of conflict of interest policies at German medical schools: a cross-sectional study and survey.

Grabitz P, Friedmann Z, Gepp S, Hess L, Specht L, Struck M BMJ Open. 2020; 10(9):e039782.

PMID: 32998930 PMC: 7528426. DOI: 10.1136/bmjopen-2020-039782.


Inadequate conflict of interest policies at most French teaching hospitals: A survey and website analysis.

Guy-Coichard C, Perraud G, Chailleu A, Gaillac V, Scheffer P, Mintzes B PLoS One. 2019; 14(11):e0224193.

PMID: 31675383 PMC: 6824557. DOI: 10.1371/journal.pone.0224193.


References
1.
Wilkes M, Hoffman J . An innovative approach to educating medical students about pharmaceutical promotion. Acad Med. 2001; 76(12):1271-7. DOI: 10.1097/00001888-200112000-00026. View

2.
Prosser H, Walley T . Understanding why GPs see pharmaceutical representatives: a qualitative interview study. Br J Gen Pract. 2003; 53(489):305-11. PMC: 1314573. View

3.
Brodkey A . The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem. Acad Psychiatry. 2005; 29(2):222-9. DOI: 10.1176/appi.ap.29.2.222. View

4.
Grande D, Frosch D, Perkins A, Kahn B . Effect of exposure to small pharmaceutical promotional items on treatment preferences. Arch Intern Med. 2009; 169(9):887-93. DOI: 10.1001/archinternmed.2009.64. View

5.
Orlowski J, Wateska L . The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest. 1992; 102(1):270-3. DOI: 10.1378/chest.102.1.270. View